Found: 19
Select item for more details and to access through your institution.
Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Combination chemotherapy with paclitaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multikinase inhibitor sorafenib induces skin toxicities in tumor-bearing mice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumab.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Population exposure-response analysis of cabozantinib efficacy and safety endpoints in patients with renal cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies.
- Published in:
- 2018
- By:
- Publication type:
- journal article